Tamoxifen and Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community health

In patients with invasive breast cancer treated in a general community health care setting, Tamoxifen, Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community and that risk progressively decreased as the duration of tamoxifen therapy increased, according to a new study published online by JAMA Oncology. ¬†About 5 percent of patients … Continue reading Tamoxifen and Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community health